Viewing Study NCT01465360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-09 @ 7:18 PM
Study NCT ID: NCT01465360
Status: COMPLETED
Last Update Posted: 2012-07-06
First Post: 2011-10-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Sponsor: Exonhit
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
None Mild Cognitive Impairment View
None Vascular Dementia View
None Fronto-temporal Dementia View
None Primary Progressive Aphasia View
None Parkinson' Disease Dementia View
None Mixed Dementia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alzheimer's disease View
None AD View
None Non AD dementia View
None Mild Cognitive Impairment View
None MCI View
None Vascular dementia View
None Fronto-temporal dementia View
None Primary progressive aphasia View
None Parkinson's Disease dementia View
None Mixed dementia View
None Blood signature View
None Diagnosis View
None AclarusDx View
None Alzheimer's Disease and other non-AD dementia View
None Exonhit View